Cleveland-Cliffs saw the highest growth of 0.99% in patent filings and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Cleveland-Cliffs‘s patent filings and grants. Buy the databook here.
Cleveland-Cliffs has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 67% of grants. The South Korea(KR), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Cleveland-Cliffs is filings its patents. Among the top granted patent authorities, Cleveland-Cliffs has 67% of its grants in European Patent Office(EPO) and 33% in United States(US).
POSCO could be the strongest competitor for Cleveland-Cliffs
Patents related to nanomedicine and nano tech lead Cleveland-Cliffs's portfolio
Cleveland-Cliffs has the highest number of patents in nanomedicine followed by, nano tech. For nanomedicine no patents were filed and 50% of patents were granted in Q2 2024.
Paints and inks related patents lead Cleveland-Cliffs portfolio
Cleveland-Cliffs has highest number of patents in paints and inks.
For comprehensive analysis of Cleveland-Cliffs's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.